PANRETIN is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Alitretinoin.
Product ID | 59212-601_1629bcf4-47bc-4203-878f-c7daeb6e8fc7 |
NDC | 59212-601 |
Product Type | Human Prescription Drug |
Proprietary Name | PANRETIN |
Generic Name | Alitretinoin |
Dosage Form | Gel |
Route of Administration | TOPICAL |
Marketing Start Date | 2019-09-10 |
Marketing Category | NDA / NDA |
Application Number | NDA020886 |
Labeler Name | Concordia Pharmaceuticals Inc. |
Substance Name | ALITRETINOIN |
Active Ingredient Strength | 60 mg/60g |
Pharm Classes | Retinoid [EPC],Retinoids [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-09-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020886 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-09-10 |
Ingredient | Strength |
---|---|
ALITRETINOIN | 60 mg/60g |
SPL SET ID: | 49c16717-7d86-4257-80c9-baa1417e5555 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
59212-601 | PANRETIN | alitretinoin |
62856-601 | Panretin | Alitretinoin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PANRETIN 74700355 2149627 Live/Registered |
EISAI INC. 1995-07-12 |